Benefits
Blood pressure reduction
Potassium supplementation reduces systolic blood pressure by approximately 3.5 mmHg and diastolic by 2.0 mmHg vs control. Effect size is substantially larger in hypertensive adults — often double the reduction seen in normotensives. The mechanism involves both renal sodium excretion (natriuresis) and direct vascular smooth muscle relaxation. Useful as a dietary lever alongside reduced sodium intake and antihypertensive medications.
Stroke and cardiovascular event reduction
A landmark cluster-randomized trial of nearly 21,000 high-risk Chinese adults using a 25% potassium-enriched salt substitute documented a 14% reduction in stroke, 13% reduction in major cardiovascular events, and 12% reduction in all-cause mortality over 4.74 years. Hyperkalemia was not increased. This is the strongest outcome-trial evidence to date that increasing potassium intake reduces hard cardiovascular endpoints — not just blood pressure as a surrogate marker.
Kidney stone prevention
Potassium citrate alkalinizes urine and reduces urinary calcium excretion, significantly lowering risk of calcium oxalate stone formation. FDA-approved as the prescription drug Urocit-K® for recurrent nephrolithiasis. Higher dietary potassium intake (from fruits and vegetables) is associated with lower lifetime stone risk in cohort studies — useful for both prevention and recurrence reduction in stone-forming patients.
Muscle function and cramp prevention
Potassium is essential for muscle membrane repolarization after each contraction. Hypokalemia causes muscle weakness, cramps, and fatigue — particularly common in athletes with high sweat losses, people on thiazide or loop diuretics, and those with chronic vomiting or diarrhea. Adequate dietary intake (4,000+ mg/day) prevents most muscle-related symptoms in otherwise healthy adults.
Fluid balance and electrolyte support
As the dominant intracellular cation, potassium pairs with extracellular sodium to maintain the osmotic gradient that regulates cell volume, nerve impulse transmission, and muscle function. Sweat losses during prolonged exercise are typically 100-300 mg/hour. Low-carb and ketogenic diets increase renal potassium excretion, often requiring higher dietary potassium to prevent fatigue and cramping during the adaptation period.
Most adults are severely under-consuming
NHANES dietary surveys show fewer than 3% of US adults meet the 4,700 mg/day Adequate Intake from food. Median actual intake is around 2,500 mg/day — roughly half the target. Top USDA food sources per typical serving: white potatoes (~926 mg/medium), spinach (~840 mg/cup cooked), beans (~700 mg/cup), yogurt (~625 mg/cup), salmon (~534 mg/3 oz), avocados (~485 mg), bananas (~422 mg). Most cardiovascular benefit comes from hitting 3,500+ mg/day from food.
Mechanism of action
Sodium-potassium ATPase pump
Na+/K+-ATPase pumps maintain the steep potassium gradient across cell membranes, which is the foundation of the resting membrane potential in all excitable cells (neurons, cardiac, skeletal muscle). This single pump consumes approximately 20-30% of basal metabolic energy and is the biological basis for both neural transmission and muscle contraction.
Renal natriuresis
High potassium intake stimulates aldosterone-independent renal sodium excretion, directly lowering blood volume and blood pressure. This mechanism explains potassium's antihypertensive effect and is distinct from (but complementary to) reducing dietary sodium intake. The two approaches together produce additive BP benefit.
Vascular smooth muscle relaxation
Potassium activates membrane hyperpolarization in vascular smooth muscle cells via K+ channel opening, causing vasodilation and reduced peripheral resistance. Complementary mechanism to renal natriuresis — both contribute to the blood pressure effect through different physiological pathways. Also contributes to endothelial nitric oxide release.
Urinary alkalinization and calcium retention
Potassium citrate specifically raises urinary pH, reducing the acid load on bone (which would otherwise leach calcium for buffering) and reducing urinary calcium excretion. This dual effect underlies both the kidney stone prevention application and the potential bone-protective effects of higher fruit/vegetable intake.
Clinical trials
Large cluster-randomized open trial evaluating a 25% potassium-enriched salt substitute (75% NaCl + 25% KCl) vs regular salt for cardiovascular outcomes in high-risk adults. Conducted across 600 rural villages in China. Primary outcomes: stroke, major cardiovascular events, all-cause mortality. Published in NEJM 2021;385:1067-1077.
20,995 high-risk adults (prior stroke or ≥60 years with hypertension). 4.74-year median follow-up.
The potassium-enriched salt substitute reduced stroke by 14%, major cardiovascular events by 13%, and all-cause mortality by 12% vs regular salt. Hyperkalemia (high blood potassium) was not increased despite the intervention being delivered to a high-risk population. The strongest outcome-trial evidence to date that increasing potassium intake reduces hard cardiovascular endpoints.
Evidence review and pooled analysis commissioned by the World Health Organization to inform global potassium intake guidelines. Pooled analysis of randomized controlled trials of potassium supplementation for blood pressure outcomes. Published in BMJ.
1,606 participants across 22 clinical trials. Various supplementation durations and potassium forms.
Increased potassium intake reduced systolic blood pressure by 3.49 mmHg (95% CI -5.16 to -1.82) and diastolic by 1.96 mmHg vs control. Effects were substantially larger in hypertensive adults compared to normotensives. Foundational evidence base supporting the WHO and AHA recommendations for 3,500-4,700 mg/day potassium intake.
Dose-response pooled analysis limited to post-2000 trials using 24-hour urinary potassium excretion as the intervention proxy (a more accurate measure than self-reported intake). 10 clinical trials included covering both normotensive and hypertensive populations. Modern methodology complementing the earlier WHO analysis.
10 clinical trials (4 in normotensive adults, 6 in hypertensive adults). Various supplementation periods.
Linear, quadratic, and threshold dose-response relationships were evaluated. Blood pressure reduction is dose-dependent across the typical supplementation range (1,500-4,700 mg/day). Effects emerge at intakes above approximately 2,500-3,000 mg/day, with larger reductions in individuals with higher baseline sodium intake.